Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

B and T lymphocyte attenuator marker for use in adoptive T-cell therapy

US Patent 9512401 · Granted Dec 6, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of CD40 and toll like receptor immune activation2024
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof2024
Monoclonal and humanized antibodies to a cancer glycopeptide2023
Methods of CD40 activation and immune checkpoint blockade2023
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy2022
Programmed death 1 ligand 1 (PD-L1) binding proteins and methods of use thereof2021
Combination of topoisomerase-I inhibitors with immunotherapy in the treatment of2021
Tumor antigens BFA4 and BCY1 for prevention and / or treatment of cancer2015
Monoclonal antibodies and uses thereof2014
Monoclonal antibodies and uses thereof2013
Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and th2012
Chimeric receptor genes and cells transformed therewith2012